NCT00000868View on ClinicalTrials.gov

A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

Not specified

Study Completion Date

May 31, 2000

Conditions
HIV InfectionsHIV Seronegativity
Interventions
BIOLOGICAL

Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203)

BIOLOGICAL

Aluminum hydroxide

BIOLOGICAL

MF59

BIOLOGICAL

rgp120/HIV-1MN

Trial Locations (1)

21205

JHU AVEG, Baltimore

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000868 - A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers | Biotech Hunter | Biotech Hunter